Nanobiotix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Nanobiotix and buy or sell other stocks, ETFs, and their options commission-free!About NBTX
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells.
CEOLaurent Lévy
CEOLaurent Lévy
Employees108
Employees108
HeadquartersParis, Ile-de-France
HeadquartersParis, Ile-de-France
Founded2003
Founded2003
Employees108
Employees108
NBTX Key Statistics
Market cap1.54B
Market cap1.54B
Price-Earnings ratio-39.55
Price-Earnings ratio-39.55
Dividend yield—
Dividend yield—
Average volume76.06K
Average volume76.06K
High today$32.84
High today$32.84
Low today$31.49
Low today$31.49
Open price$32.84
Open price$32.84
Volume31.64K
Volume31.64K
52 Week high$41.89
52 Week high$41.89
52 Week low$2.99
52 Week low$2.99
NBTX News
TipRanks 5h
Nanobiotix Updates Share Capital and Voting Rights as of February 28, 2026Nanobiotix ( (NBTX) ) has shared an announcement. Nanobiotix S.A. is a late-stage clinical biotechnology group headquartered in Paris that focuses on physics-b...
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.